Cardiology Research and Practice最新文献

筛选
英文 中文
Comparative Analysis of Hypertension Guidelines: Unveiling Consensus and Discrepancies in Lifestyle Modifications for Blood Pressure Control 高血压指南比较分析:揭示控制血压的生活方式调整方面的共识与分歧
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-12-12 DOI: 10.1155/2023/5586403
Yi Wang, Yanxiang Liu, Lu Liu, Liqiong Hong, Huimin Chen
{"title":"Comparative Analysis of Hypertension Guidelines: Unveiling Consensus and Discrepancies in Lifestyle Modifications for Blood Pressure Control","authors":"Yi Wang, Yanxiang Liu, Lu Liu, Liqiong Hong, Huimin Chen","doi":"10.1155/2023/5586403","DOIUrl":"https://doi.org/10.1155/2023/5586403","url":null,"abstract":"<i>Background</i>. Hypertension is a major global health concern, and lifestyle modifications have been recommended as first-line treatment for hypertension in many guidelines. However, different guidelines may recommend different types of lifestyle adjustment, and it is unclear which ones are most effective. In this review, we compared hypertension guidelines to identify any differences and/or consensus in content, efficacy, and timing of initiation of lifestyle modifications. <i>Methods</i>. We conducted a search of databases to identify hypertension guidelines available in English. We extracted and compared information about lifestyle modifications recommended by the guidelines. <i>Results</i>. Five hypertension guidelines from America, Europe, the UK, Canada, and the International Society of Hypertension are included. They all recommend diet adaptation, sodium reduction, alcohol restriction, physical exercise, and weight reduction. Other lifestyle interventions emphasized by some guidelines, such as potassium supplementation, smoking cessation, and stress management, are not recommended by all the five guidelines. Among lifestyle changes, the dietary approaches to stop hypertension (DASH) diet may be considered the most effective treatment for reducing blood pressure. These guidelines recommend that for patients with high-normal blood pressure or grade 1 hypertension without high risk factors, lifestyle medicine should be used first for 3–6 months, if blood pressure is still not controlled, then start medication. For those patients who need drug treatment, lifestyle changes can also enhance the effects of antihypertensive therapy. <i>Conclusion</i>. Lifestyle modifications are crucial in the treatment of hypertension and should be recommended to most hypertensive patients. Among these lifestyle interventions, diet adaptation containing low sodium and alcohol restriction may be the most effective in reducing blood pressure. Physical exercise and weight reduction are also recommended. In some cases, lifestyle modifications should be tried first. They may also enhance the effects of antihypertensive drugs in other patients.","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"1 1","pages":""},"PeriodicalIF":2.1,"publicationDate":"2023-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138575701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Left Atrial Function in Patients with Paroxysmal Atrial Fibrillation Using Left Atrial Automatic Myocardial Functional Imaging Ultrasonography. 应用左心房自动心肌功能显像超声评价阵发性心房颤动患者的左心房功能。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-11-20 eCollection Date: 2023-01-01 DOI: 10.1155/2023/6924570
Hailan Liu, Lili Chen, Yan Song, Yingying Xu, Chunquan Zhang
{"title":"Evaluation of Left Atrial Function in Patients with Paroxysmal Atrial Fibrillation Using Left Atrial Automatic Myocardial Functional Imaging Ultrasonography.","authors":"Hailan Liu, Lili Chen, Yan Song, Yingying Xu, Chunquan Zhang","doi":"10.1155/2023/6924570","DOIUrl":"https://doi.org/10.1155/2023/6924570","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To evaluate volume and strain of the left atrium (LA) in people suffering from paroxysmal atrial fibrillation which is not valvular (NVPAF) using the new technology of left atrial automatic myocardial function imaging (AFILA) and to analyze prognostic factors in patients with NVPAF by follow-up.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Between August 2019 and August 2022, a total of 80 NVPAF patients and 60 normal control patients who were hospitalized in the Department of Cardiology were included in the study. The LA volume and strain parameters of the two groups were analyzed. The differences in LA function (LAF) parameters were compared between the two groups to generate the receiver operating characteristic curve (ROC) and calculate the area under the curve (AUC), sensitivity, and specificity of each parameter. Follow-up was conducted on the 80 NVPAF patients included, their treatment methods after admission and their rehospitalization due to heart events were recorded, and independent risk factors influencing the prognosis of NVPAF were obtained.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 140 patients participated in the study, including 80 in the NVPAF group and 60 in the normal control group. There was no statistically significant difference in age and sex between the two groups. Compared to the normal group, the LA minimum volume (LAVmin), LA maximum volume (LAVmax), and volume at onset of LA contraction (LAVpreA) in the NVPAF group were significantly increased. The LA emptying fraction (LAEF) was significantly decreased, and LA reservoir strain (S_R), LA conduit strain (S_CD), and LA contractile strain (S_CT) were significantly compromised (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). There was no significant difference in LA evacuation volume (LAEV) reduction (&lt;i&gt;P&lt;/i&gt; &gt; 0.05). Logistic regression analysis of LAF parameters in NVPAF patients showed that LAEF and S_R were independently correlated with NVPAF (odds ratio values: 0.883 (0.827-0.943), &lt;i&gt;P&lt;/i&gt; &lt; 0.001; 0.916 (0.569-1.474), &lt;i&gt;P&lt;/i&gt; = 0.047). The ROC curve results showed that LAEF had a high efficiency in the diagnosis of NVPAF, with &lt;i&gt;P&lt;/i&gt; &lt; 0.001, AUC of 0.843, sensitivity of 0.788, and specificity of 0.867. For the LA strain parameters, the S_R test efficiency was higher, with &lt;i&gt;P&lt;/i&gt; &lt; 0.001, AUC of 0.762, sensitivity of 0.713, and specificity of 0.783. There was a strong correlation between S_R and LAEF in patients with no end event and those with end event. The ROC curve revealed that the S_R was better than LAEF in predicting prognosis of patients with AF (AUC = 0.914, &lt;i&gt;P&lt;/i&gt; &lt; 0.0001 vs. AUC = 0.876, &lt;i&gt;P&lt;/i&gt; &lt; 0.0001). S_R of 10.5 and LAEF of 21 were the cut-off values for endpoint events in NVPAF patients, with sensitivity of 0.909 and 0.727 and specificity of 0.904 and 0.901, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;AFILA ultrasound technology comprehensively evaluated the LA size and function in patients with NVPAF. The LAEF and S_R were independently correlate","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"6924570"},"PeriodicalIF":2.1,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681773/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138458071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy 肥厚性心肌病患者植入式心律转复除颤器的并发症及其潜在危险因素
4区 医学
Cardiology Research and Practice Pub Date : 2023-11-13 DOI: 10.1155/2023/4552100
Mohammad Taghi Hedayati Goudarzi, Maryam Moradi, Saeed Abrotan, Mehrdad Saravi, Hoda Shirafkan, Rana Irilouzadian, Hossein Salehi Omran
{"title":"Complications of Implantable Cardioverter Defibrillator and Their Potential Risk Factors in Patients with Hypertrophic Cardiomyopathy","authors":"Mohammad Taghi Hedayati Goudarzi, Maryam Moradi, Saeed Abrotan, Mehrdad Saravi, Hoda Shirafkan, Rana Irilouzadian, Hossein Salehi Omran","doi":"10.1155/2023/4552100","DOIUrl":"https://doi.org/10.1155/2023/4552100","url":null,"abstract":"Background. Hypertrophic cardiomyopathy (HCM) has different complications such as cardiac arrhythmia and sudden cardiac death (SCD). Insertion of an implantable cardioverter defibrillator (ICD) is recommended for HCM patients who are at high risk of SCD and malignant arrhythmias, despite having their own potential complications. Hypothesis. We aimed to investigate the prevalence of different complications of ICD insertion and the impact of the potential influential baseline characteristics in a one-year follow-up period. Methods. This was a retrospective study with a total of 71 HCM patients with ICD insertion. We evaluated the prevalence of different complications of ICD implantation and the impact of baseline characteristics on the occurrence of ICD complications using multivariate regression analysis in three 4-month periods. Results. In a one-year follow-up, 13 patients (18.3%) experienced at least one of the complications including pneumothorax, lead failure, ICD infection, inappropriate shocks, perforation, and upper limb deep vein thrombosis (DVT) with no mortality. Inappropriate shocks were reported as the most common (11.3%) complication during this period, with a gradual increase in the second (4.2%) and third (5.6%) follow-up sessions. Among all of the baseline characteristics that were investigated in this study, a positive history of hypertension was the only risk factor with significant impact on the occurrence of complications ( <math xmlns=\"http://www.w3.org/1998/Math/MathML\" id=\"M1\"> <mi>P</mi> </math> = 0.01). Conclusion. We demonstrated the occurrence of complications during a one-year follow-up as 18.3% in HCM patients with ICD insertion. A positive history of hypertension was the only baseline characteristic affecting the occurrence of complications, and inappropriate shocks were the most common complication.","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"68 20","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136281842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Risk Factors of Postprocedure Depression in Patients with Atrial Fibrillation after Radiofrequency Ablation 心房颤动射频消融患者术后抑郁的患病率及危险因素
4区 医学
Cardiology Research and Practice Pub Date : 2023-11-07 DOI: 10.1155/2023/4635336
Mingli Du, Tieniu Cheng, Yutong Ye, Yong Wei
{"title":"Prevalence and Risk Factors of Postprocedure Depression in Patients with Atrial Fibrillation after Radiofrequency Ablation","authors":"Mingli Du, Tieniu Cheng, Yutong Ye, Yong Wei","doi":"10.1155/2023/4635336","DOIUrl":"https://doi.org/10.1155/2023/4635336","url":null,"abstract":"Background. Recent studies have shown a bidirectional relationship between atrial fibrillation (AF) and psychological depression. However, little is known about the prevalence of postprocedure depression (PPD) in patients with AF at the time of radiofrequency (RF) ablation. Objective. To describe the prevalence and identify risk factors for PPD. Methods. This was a prospective cohort study, including 428 AF patients who were willing to undergo the first catheter ablation in our hospital from 1st April to 30th December 2019. The primary outcome was PPD, which was determined by Hospital Anxiety and Depression Scale-Depression. Results. The prevalence of PPD was 16.8% (72/428) in our cohort, without difference between men (16.0%, 41/256) and women (18.0%, 31/172) (P = 0.586) but with a great difference among different age groups (P = 0.016). On the univariable binary logistic regression analysis, age, a history of coronary heart disease, Observer’s Assessment of Alertness/Sedation (OAA/S) score when ablating at the specific position, and OAA/S score when pulling out the catheter sheath were associated with PPD. Subsequent multivariable logistic regression analysis indicated only age (OR 0.96, 95% CI: 0.94–0.99, <math xmlns=\"http://www.w3.org/1998/Math/MathML\" id=\"M1\"> <mi>P</mi> <mo><</mo> <mtext> </mtext> <mn>0.01</mn> </math> ) and OAA/S score when ablating at the specific position (OR 0.58, 95% CI: 0.39–0.88, P = 0.01) were independently associated with PPD. Conclusion. PPD is common in patients with AF after RF ablation. Younger age and lower OAA/S score when ablating at the specific position are its most significant risk factors. Intensive management of sedation may be of great importance for reducing PPD. This trial is registered with the Chinese Clinical Trial Registry (ChiCTR2200057810).","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"9 5","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135433077","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bachmann's Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy. Bachmann氏束改良加环肺静脉隔离治疗心房颤动:一种新的消融策略。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-27 eCollection Date: 2023-01-01 DOI: 10.1155/2023/2870188
Jiaqi Sun, Sanbao Chen, Ming Liang, Qi Zhang, Ping Zhang, Mingyu Sun, Jian Ding, Zhiqing Jin, Yaling Han, Zulu Wang
{"title":"Bachmann's Bundle Modification in Addition to Circumferential Pulmonary Vein Isolation for Atrial Fibrillation: A Novel Ablation Strategy.","authors":"Jiaqi Sun,&nbsp;Sanbao Chen,&nbsp;Ming Liang,&nbsp;Qi Zhang,&nbsp;Ping Zhang,&nbsp;Mingyu Sun,&nbsp;Jian Ding,&nbsp;Zhiqing Jin,&nbsp;Yaling Han,&nbsp;Zulu Wang","doi":"10.1155/2023/2870188","DOIUrl":"https://doi.org/10.1155/2023/2870188","url":null,"abstract":"<p><strong>Background: </strong>Bachmann's bundle (BB) is the main pathway of interatrial connection that could be involved in the development of atrial fibrillation (AF). Based on this hypothesis, we raised a novel ablation strategy, BB modification in addition to circumferential pulmonary vein isolation (CPVI-BB) in patients with AF.</p><p><strong>Methods: </strong>A retrospective cohort of patients with AF who underwent CPVI-BB or CPVI alone from March 2018 to July 2021 was enrolled in our study. Propensity score matching was performed in patients with paroxysmal AF and persistent AF, respectively, to reduce the risk of selection bias between the treatment strategies (CPVI-BB or CPVI alone). The primary endpoint was overall freedom from atrial arrhythmia recurrence through 12 months of follow-up.</p><p><strong>Results: </strong>Our propensity score-matched cohort included 82 patients with paroxysmal AF (CPVI group: <i>n</i> = 41; CPVI-BB group: <i>n</i> = 41) and 168 patients with persistent AF (CPVI group: <i>n</i> = 84; CPVI-BB group: <i>n</i> = 84). Among patients with persistent AF, one-year freedom from atrial arrhythmia recurrence rate was 83.3% in the CPVI-BB group and 70.2% in the CPVI group (log-rank <i>P</i> = 0.047). Among patients with paroxysmal AF, no significant difference was found in the primary endpoint between two groups (85.4% in the CPVI-BB group vs. 80.5% in the CPVI group; log-rank <i>P</i> = 0.581). In addition, procedure-related complications and recurrence of atrial tachycardia or atrial flutter were similar between the two treatment groups, regardless of the type of AF.</p><p><strong>Conclusions: </strong>BB modification in addition to CPVI is an effective approach in increasing the maintenance of sinus rhythm in patients with persistent AF, while it does not improve the clinical outcomes of radiofrequency catheter ablation in patients with paroxysmal AF.</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"2870188"},"PeriodicalIF":2.1,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624549/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71478362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Development and Validation of a Risk Prediction Model for Ventricular Arrhythmia in Elderly Patients with Coronary Heart Disease. 收回:老年冠心病患者室性心律失常风险预测模型的开发和验证。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9846248
Cardiology Research And Practice
{"title":"Retracted: Development and Validation of a Risk Prediction Model for Ventricular Arrhythmia in Elderly Patients with Coronary Heart Disease.","authors":"Cardiology Research And Practice","doi":"10.1155/2023/9846248","DOIUrl":"10.1155/2023/9846248","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/2283018.].</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"9846248"},"PeriodicalIF":2.1,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Decreased Spp1 Expression in Acute Myocardial Infarction after Ischemia and Reperfusion Injury. 收缩:急性心肌梗死缺血再灌注损伤后Spp1表达降低。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9870810
Cardiology Research And Practice
{"title":"Retracted: Decreased Spp1 Expression in Acute Myocardial Infarction after Ischemia and Reperfusion Injury.","authors":"Cardiology Research And Practice","doi":"10.1155/2023/9870810","DOIUrl":"10.1155/2023/9870810","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/3925136.].</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"9870810"},"PeriodicalIF":2.1,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586380/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients. 收缩:年轻非糖尿病冠心病患者的高密度脂蛋白胆固醇。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9796524
Cardiology Research And Practice
{"title":"Retracted: High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients.","authors":"Cardiology Research And Practice","doi":"10.1155/2023/9796524","DOIUrl":"10.1155/2023/9796524","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/2970568.].</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"9796524"},"PeriodicalIF":2.1,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Establishment of a Nomogram for Predicting Early Death in Viral Myocarditis. 收回:建立预测病毒性心肌炎早期死亡的诺模图。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9831278
Cardiology Research And Practice
{"title":"Retracted: Establishment of a Nomogram for Predicting Early Death in Viral Myocarditis.","authors":"Cardiology Research And Practice","doi":"10.1155/2023/9831278","DOIUrl":"10.1155/2023/9831278","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/9947034.].</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"9831278"},"PeriodicalIF":2.1,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retracted: Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries. 收回:验证肺血流研究在纠正主主动脉-肺副动脉肺闭锁和室间隔缺损中的有用性。
IF 2.1 4区 医学
Cardiology Research and Practice Pub Date : 2023-10-11 eCollection Date: 2023-01-01 DOI: 10.1155/2023/9860567
Cardiology Research And Practice
{"title":"Retracted: Verifying the Usefulness of Pulmonary Blood Flow Studies in the Correction of Pulmonary Atresia and Ventricular Septal Defect with Major Aortopulmonary Collateral Arteries.","authors":"Cardiology Research And Practice","doi":"10.1155/2023/9860567","DOIUrl":"10.1155/2023/9860567","url":null,"abstract":"<p><p>[This retracts the article DOI: 10.1155/2021/3483976.].</p>","PeriodicalId":9494,"journal":{"name":"Cardiology Research and Practice","volume":"2023 ","pages":"9860567"},"PeriodicalIF":2.1,"publicationDate":"2023-10-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586337/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49688845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信